Purpose: To explore the role of vacuum assisted closure (VAC) therapy versus conventional dressings in the Fournier’s gangrene wound therapy. Patients and Methods: This is a retrospective multi-institutional cohort study. Data of 92 patients from nine centers between 2007 and 2018 were retrospectively analyzed. After surgery, patient having a local or a disseminated FG were managed with VAC therapy or with conventional dressings. The 10-weeks wound closure cumulative rate and OS were analyzed. Results: Of the 92 patients, 62 (67.4%) showed local and 30 (32.6%) a disseminated FG. After surgery, 19 patients (20.7%) with local and 14 (15.2%) with disseminated FG underwent to VAC therapy; 43 (46.7%) with local and 16 (17.4%) with disseminated FG were treated using conventional dressings. The multivariable logistic regression analysis demonstrated that the VAC in patients with disseminated FG led to a higher cumulative rate of wound closure than patients treated with no-VAC (OR = 6.5; 95% CI 1.1–37.4, p = 0.036). The Kaplan–Meier survival curves for the OS showed a significant difference between no-VAC patients with local and disseminated FG (OS rate at 90 days 0.90, 95% CI 0.71–0.97 vs 0.55, 95% CI 0.24–0.78, respectively; p = 0.039). Cox regression confirmed that no-VAC patients with disseminated FG showed the lowest OS (hazard ratio adjusted for sex and age HR = 3.4, 95% CI 1.1–10.4; p = 0.033). Conclusions: In this large cohort study, VAC therapy in patients with disseminated FG may offer an advantage in terms of 10-weeks wound closure cumulative rate and OS at 90 days after initial surgery.

The role of vacuum-assisted closure (VAC) therapy in the management of FOURNIER’S gangrene: a retrospective multi-institutional cohort study / Iacovelli, V.; Cipriani, C.; Sandri, M.; Filippone, R.; Ferracci, A.; Micali, S.; Rocco, B.; Puliatti, S.; Ferrarese, P.; Benedetto, G.; Minervini, A.; Cocci, A.; Pastore, A. L.; Al Salhi, Y.; Antonelli, A.; Morena, T.; Volpe, A.; Poletti, F.; Celia, A.; Zeccolini, G.; Leonardo, C.; Proietti, F.; Finazzi Agro, E.; Bove, P.. - In: WORLD JOURNAL OF UROLOGY. - ISSN 0724-4983. - (2020), pp. 1-8. [10.1007/s00345-020-03170-7]

The role of vacuum-assisted closure (VAC) therapy in the management of FOURNIER’S gangrene: a retrospective multi-institutional cohort study

Sandri M.;Micali S.;Rocco B.;Puliatti S.;
2020-01-01

Abstract

Purpose: To explore the role of vacuum assisted closure (VAC) therapy versus conventional dressings in the Fournier’s gangrene wound therapy. Patients and Methods: This is a retrospective multi-institutional cohort study. Data of 92 patients from nine centers between 2007 and 2018 were retrospectively analyzed. After surgery, patient having a local or a disseminated FG were managed with VAC therapy or with conventional dressings. The 10-weeks wound closure cumulative rate and OS were analyzed. Results: Of the 92 patients, 62 (67.4%) showed local and 30 (32.6%) a disseminated FG. After surgery, 19 patients (20.7%) with local and 14 (15.2%) with disseminated FG underwent to VAC therapy; 43 (46.7%) with local and 16 (17.4%) with disseminated FG were treated using conventional dressings. The multivariable logistic regression analysis demonstrated that the VAC in patients with disseminated FG led to a higher cumulative rate of wound closure than patients treated with no-VAC (OR = 6.5; 95% CI 1.1–37.4, p = 0.036). The Kaplan–Meier survival curves for the OS showed a significant difference between no-VAC patients with local and disseminated FG (OS rate at 90 days 0.90, 95% CI 0.71–0.97 vs 0.55, 95% CI 0.24–0.78, respectively; p = 0.039). Cox regression confirmed that no-VAC patients with disseminated FG showed the lowest OS (hazard ratio adjusted for sex and age HR = 3.4, 95% CI 1.1–10.4; p = 0.033). Conclusions: In this large cohort study, VAC therapy in patients with disseminated FG may offer an advantage in terms of 10-weeks wound closure cumulative rate and OS at 90 days after initial surgery.
1
8
The role of vacuum-assisted closure (VAC) therapy in the management of FOURNIER’S gangrene: a retrospective multi-institutional cohort study / Iacovelli, V.; Cipriani, C.; Sandri, M.; Filippone, R.; Ferracci, A.; Micali, S.; Rocco, B.; Puliatti, S.; Ferrarese, P.; Benedetto, G.; Minervini, A.; Cocci, A.; Pastore, A. L.; Al Salhi, Y.; Antonelli, A.; Morena, T.; Volpe, A.; Poletti, F.; Celia, A.; Zeccolini, G.; Leonardo, C.; Proietti, F.; Finazzi Agro, E.; Bove, P.. - In: WORLD JOURNAL OF UROLOGY. - ISSN 0724-4983. - (2020), pp. 1-8. [10.1007/s00345-020-03170-7]
Iacovelli, V.; Cipriani, C.; Sandri, M.; Filippone, R.; Ferracci, A.; Micali, S.; Rocco, B.; Puliatti, S.; Ferrarese, P.; Benedetto, G.; Minervini, A.; Cocci, A.; Pastore, A. L.; Al Salhi, Y.; Antonelli, A.; Morena, T.; Volpe, A.; Poletti, F.; Celia, A.; Zeccolini, G.; Leonardo, C.; Proietti, F.; Finazzi Agro, E.; Bove, P.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1207194
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 11
social impact